Clinical impact of amyloid PET using (18)F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study

OBJECTIVE: Amyloid positron emission tomography (PET) can reliably detect senile plaques and fluorinated ligands are approved for clinical use. However, the clinical impact of amyloid PET imaging is still under investigation. The aim of this study was to evaluate the diagnostic impact and clinical u...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Hiroshi, Okita, Kyoji, Motoi, Yumiko, Mizuno, Toshiki, Ikeda, Manabu, Sanjo, Nobuo, Murakami, Koji, Kambe, Taiki, Takayama, Toshiki, Yamada, Kei, Suehiro, Takashi, Matsunaga, Keiko, Yokota, Takanori, Tateishi, Ukihide, Shigemoto, Yoko, Kimura, Yukio, Chiba, Emiko, Kawashima, Takahiro, Tomo, Yui, Tachimori, Hisateru, Kimura, Yuichi, Sato, Noriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668773/
https://www.ncbi.nlm.nih.gov/pubmed/36194355
http://dx.doi.org/10.1007/s12149-022-01792-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668773/
https://www.ncbi.nlm.nih.gov/pubmed/36194355
http://dx.doi.org/10.1007/s12149-022-01792-y

Ejemplares similares